Abstract
Background: Due to the advances in catheter-based interventional techniques, a wide range of heart diseases can now be treated with a purely interventional approach. Little is yet known regarding biological effects at the intracardiac implantation site or the effects on endothelialization and vascular inflammation in an in vivo environment. Detailed knowledge of ongoing vascular response, the process of endothelialization, and possible systemic inflammatory reactions after implantation is crucial for the clinical routine, since implants usually remain in the body for a lifetime.
Methods: For this narrative review, we conducted an extensive profound PubMed analysis of the current literature on the endothelialization processes of intracardially implanted devices, such as persistent foramen ovale (PFO) occluders, atrial septal defect (ASD) occluders, left atrial appendage (LAA) occluders, transcatheter aortic valve implantations (TAVIs), and leadless pacemakers. Additionally, the known biological activities of common metallic and synthetic components of intracardiac devices in an “in vivo” setting have been evaluated.
Results: Nitinol, an alloy of nickel and titanium, is by far the most commonly used material found in intracardiac devices. Although allergies to both components are known, implantation can be performed safely in the vast majority of patients. Depending on the device used, endothelialization can be expected within a time frame of 3–6 months. For those patients with a known allergy, gold coating may be considered as a viable alternative.
Conclusion: Based on our analysis, we conclude that the vast majority of devices are made of a material that is both safe to implant and nontoxic in long-term treatment according to the current knowledge. The literature on the respective duration of endothelialization of individual devices however is highly divergent.
The authors declare that there is no conflict of interests regarding the publication of this paper. All companies have granted image rights to depict their devices in this article.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- ASD:
-
Atrial Septal Defect
- ASO:
-
Amplatzer Septal Occluder
- ATP:
-
Adenosine Triphosphate
- CMs:
-
Cardiomyocytes
- DAMPs:
-
Damage-Associated Patterns
- ECs:
-
Endothelial Cells
- ECM:
-
Extracellular Matrix
- EPCs:
-
Endothelial Progenitor Cells
- GSO:
-
Gore Septal Occluder
- HMGB1:
-
High-mobility Group B1
- HSPs:
-
Heat Shock Proteins
- ICAM-1:
-
Intercellular Adhesion Molecule 1
- IFN-γ:
-
Interferon Gamma
- LAA:
-
Left Atrial Appendage
- MERTK:
-
Myeloid–Epithelial–Reproductive Tyrosine Kinase
- MMPs:
-
Matrix Metalloproteinases
- MI:
-
Myocardial Infarction
- NOAC:
-
New/“Non-Vitamin K” – Oral Anticoagulants
- PCI:
-
Percutaneous Coronary Intervention
- PDGF:
-
Platelet-Derived Growth Factor
- PET:
-
Polyethylene Terephthalate
- PFO:
-
Persistent Foramen Ovale
- PRRs:
-
Pattern Recognition Receptors
- RAGE:
-
Receptor for Advanced Glycation End Products
- ROS:
-
Reactive Oxygen Species
- SMCs:
-
Smooth Muscle Cells
- TAVI:
-
Transcatheter Aortic Valve Implantation
- TGF-β:
-
Transforming Growth Factor Beta
- TLRs:
-
Toll-Like Receptors
- Treg:
-
Regulatory T-cells
- VEGF:
-
Vascular Endothelial Growth Factor
- VSD:
-
Ventricular Septal Defect
References
Akpek M, Kaya MG, Lam YY, Sahin O, Elcik D, Celik T, Ergin A, Gibson CM (2012) Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 110:621–627
Alli O, Holmes DR (2015) Left atrial appendage occlusion for stroke prevention. Curr Probl Cardiol 40:429–476
Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, Buss S, Autschbach F, Pleger ST, Lukic IK (2008) High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117:3216
Anderson RH (2016) Development of the atrial septum. Heart 102:481
Anderson RH, Brown NA, Webb S (2002) Development and structure of the atrial septum. Heart 88:104–110
Ar IG, Senning A, Siegenthaler WE (1979) Non-operative dilatation of coronary artery stenosis. N Engl J Med 301:61–68
Arslan F, De Kleijn DP, Pasterkamp G (2011) Innate immune signaling in cardiac ischemia. Nat Rev Cardiol 8:292
Arslan F, Smeets MB, O’Neill LA, Keogh B, Mcguirk P, Timmers L, Tersteeg C, Hoefer IE, Doevendans PA, Pasterkamp G, De Kleijn DP (2010) Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation 121:80–90
Asahara T, Murohara T, Sullivan A, Silver M, Van Der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–966
Balasundaram RP, Anandaraja S, Juneja R et al (2005) Infective endocarditis following implantation of amplatzer atrial septal occluder. Indian Heart J 57:167–169
Balistreri CR, Buffa S, Pisano C, Lio D, Ruvolo G, Mazzesi G (2015) Are endothelial progenitor cells the real solution for cardiovascular diseases? Focus on controversies and perspectives. Biomed Res Int:2015
Beltrami AP, Urbanek K, Kajstura J, Yan S-M, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA (2001) Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344:1750–1757
Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H (2009) Evidence for cardiomyocyte renewal in humans. Science 324:98–102
Bianchi ME, Crippa MP, Manfredi AA, Mezzapelle R, Rovere Querini P, Venereau E (2017) High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair. Immunol Rev 280:74–82
Bruch L, Parsi A, Grad MO, Rux S, Burmeister T, Krebs H, Kleber FX (2002) Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single-center experience. Circulation 105:2845–2848
Buijs JOD, Musters M, Verrips T, Post JA, Braam B, Van Riel N (2004) Mathematical modeling of vascular endothelial layer maintenance: the role of endothelial cell division, progenitor cell homing, and telomere shortening. Am J Phys Heart Circ Phys 287:H2651–H2658
Caiado F, Real C, Carvalho T, Dias S (2008) Notch pathway modulation on bone marrow-derived vascular precursor cells regulates their angiogenic and wound healing potential. PLoS One 3:e3752
Campbell M (1970) Natural history of atrial septal defect. Heart 32:820–826
Candinas R, Duru F, Schneider J et al (1999) Postmortem analysis of encapsulation around long-term ventricular endocardial pacing leads. Mayo Clin Proc 74:120–125
Cardoso CO, Rossi Filho RI, Machado PR et al (2007) Effectiveness of the Amplatzer device for transcatheter closure of an ostium secundum atrial septal defect. Arq Bras Cardiol 88:384–389
Chakos A, Wilson-Smith A, Arora S et al (2017) Long term outcomes of transcatheter aortic valve implantation (TAVI): a systematic review of 5-year survival and beyond. Ann Cardiothorac Surg 6:432–443
Chan JKY, Patel J, Seppanen E, Chong MS, Yeo JS, Teo EY, Fisk NM, Khosrotehrani K (2013) Prospective surface marker-based isolation and expansion of fetal endothelial colony-forming cells from human term placenta. Stem Cells Transl Med 2(11):839–847
Chavakis T, Bierhaus A, Nawroth PP (2004) RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect 6:1219–1225
Chen W, Frangogiannis NG (2013) Fibroblasts in post-infarction inflammation and cardiac repair. Biochimica et Biophysica Acta (BBA)-Mol Cell Res 1833:945–953
Cheng B, Chen H, Chou I, Tang TW, Hsieh PC (2017) Harnessing the early post-injury inflammatory responses for cardiac regeneration. J Biomed Sci 24:1–9
Chessa M, Carminati M, Cao QL et al (2002) Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device. J Invasive Cardiol 14:322–327
Corbett SA, Schwarzbauer JE (1998) Fibronectin–fibrin cross-linking: a regulator of cell behavior. Trends Cardiovasc Med 8:357–362
Cribier A, Eltchaninoff H, Bash A et al (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106:3006–3008
Čulić O, Eraković V, Čepelak I, Barišić K, Brajša K, Ferenčić Ž, Galović R, Glojnarić I, Manojlović Z, Munić V (2002) Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. Eur J Pharmacol 450:277–289
Deb A, Ubil E (2014) Cardiac fibroblast in development and wound healing. J Mol Cell Cardiol 70:47–55
Debrunner M, Schuiki E, Minder E, Straumann E, Naegeli B, Mury R, Bertel O, Frielingsdorf J (2008) Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock. Clin Res Cardiol 97:298–305
Della Rocca DG, Prete AD, Di Biase L, Horton RP, Al-Ahmad A, Bassiouny M, Mohanty S, Trivedi C, Romero J, Gianni C, Burkhardt JD, Gallinghouse GJ, Sanchez JE, Versaci F, Natale A (2019) Current endocardial approaches for left atrial appendage closure. Eur J Arrhythm Electrophysiol 5(1):40–46
Dewald O, Ren G, Duerr GD, Zoerlein M, Klemm C, Gersch C, Tincey S, Michael LH, Entman ML, Frangogiannis NG (2004) Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am J Pathol 164:665–677
Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T, Michael LH, Rollins BJ, Entman ML, Frangogiannis NG (2005) CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res 96:881–889
Diepgen TL, Ofenloch RF, Bruze M et al (2016) Prevalence of contact allergy in the general population in different European regions. Br J Dermatol 174:319–329
Dobaczewski M, Chen W, Frangogiannis NG (2011) Transforming growth factor (TGF)-β signaling in cardiac remodeling. J Mol Cell Cardiol 51:600–606
Dobaczewski M, Gonzalez-Quesada C, Frangogiannis NG (2010a) The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol 48:504–511
Dobaczewski M, Xia Y, Bujak M, Gonzalez-Quesada C, Frangogiannis NG (2010b) CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol 176:2177–2187
Duperray A, Mantovani A, Introna M, Dejana E (1995) Endothelial cell regulation of leukocyte infiltration in inflammatory tissues. Mediat Inflamm 4(5):322–330
Dvorak P, Novak M, Kamaryt P et al (2012) Histological findings around electrodes in pacemaker and implantable cardioverter-defibrillator patients: comparison of steroid-eluting and non-steroid-eluting electrodes. Europace 14:117–123
Edlinger C, Paar V, Tuscher T et al (2019) Potential mechanisms of endothelialisation in individuals implanted with a leadless pacemaker systems: an experimental in vitro study. J Electrocardiol 55:72–77
Edlinger C, Krizanic F, Butter C, Bannehr M, Neuss M, Fejzic D, Hoppe UC, Lichtenauer M (2020) Economic assessment of traditional surgical valve replacement versus use of transfemoral intervention in degenerative aortic stenosis. Minerva Med 112(3):372–383
El Faquir N, Rocatello G, Rahhab Z, Bosmans J, De Backer O, Van Mieghem NM, Mortier P, De Jaegere PP (2020) Differences in clinical valve size selection and valve size selection for patient-specific computer simulation in transcatheter aortic valve replacement (TAVR): a retrospective multicenter analysis. Int J Card Imaging 36:123–129
Eliaz N (2019) Corrosion of metallic biomaterials: a review. Materials (Basel) 12(3):407
Entman ML, Youker K, Shoji T, Kukielka G, Shappell SB, Taylor AA, Smith CW (1992) Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence. J Clin Invest 90:1335–1345
Esposito M, Kennergren C, Holmström N et al (2002) Morphologic and immunohistochemical observations of tissues surrounding retrieved transvenous pacemaker leads. J Biomed Mater Res 63:548–558
Fage SW, Muris J, Jakobsen SS et al (2016) Titanium: a review on exposure, release, penetration, allergy, epidemiology, and clinical reactivity. Contact Dermatitis 74:323–345
Fischer G, Stieh J, Uebing A et al (2003) Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single Centre study in 236 consecutive patients. Heart 89:199–204
Flick MJ, Du X, Witte DP, Jiroušková M, Soloviev DA, Busuttil SJ, Plow EF, Degen JL (2004) Leukocyte engagement of fibrin (ogen) via the integrin receptor α M β 2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest 113:1596–1606
Forssmann-Falck R (1997) Werner Forssmann: a pioneer of cardiology. Am J Cardiol 79:651–660
Fountain RB, Holmes DR, Chandrasekaran K et al (2006) The PROTECT AF (WATCHMAN left atrial appendage system for embolic PROTECTion in patients with atrial fibrillation) trial. Am Heart J 151:956–961
Frangogiannis NG (2012) Regulation of the inflammatory response in cardiac repair. Circ Res 110:159–173
Frangogiannis NG (2014) The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol 11:255–265
Frangogiannis NG (2017) The extracellular matrix in myocardial injury, repair, and remodeling. J Clin Invest 127:1600–1612
Frangogiannis NG, Lindsey ML, Michael LH, Youker KA, Bressler RB, Mendoza LH, Spengler RN, Smith CW, Entman ML (1998) Resident cardiac mast cells degranulate and release preformed TNF-α, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 98:699–710
Frangogiannis NG, Mendoza LH, Lindsey ML, Ballantyne CM, Michael LH, Smith CW, Entman ML (2000) IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J Immunol 165:2798–2808
Geissmann F, Jung S, Littman DR (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71–82
Gilles S, Zahler S, Welsch U, Sommerhoff CP, Becker BF (2003) Release of TNF-α during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. Cardiovasc Res 60:608–616
Gloire G, Legrand-Poels S, Piette J (2006) NF-κB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 72:1493–1505
Goli A, Shroff S, Osman MN, Lucke J (2012) A case of gold-coated pacemaker for pacemaker allergy. The Journal 945
Gong Y, Koh D-R (2010) Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model. Cell Tissue Res 339:437–448
González-Rosa JM, Martín V, Peralta M, Torres M, Mercader N (2011) Extensive scar formation and regression during heart regeneration after cryoinjury in zebrafish. Development 138:1663–1674
Granier M, Laugaudin G, Massin F et al (2018) Occurrence of incomplete endothelialization causing residual permeability after left atrial appendage closure. J Invasive Cardiol 30:245–250
Gretzer C, Emanuelsson L, Liljensten E, Thomsen P (2006) The inflammatory cell influx and cytokines changes during transition from acute inflammation to fibrous repair around implanted materials. J Biomater Sci Polym Ed 17:669–687
Greutmann M, Greutmann-Yantiri M, Kretschmar O, Senn O, Roffi M, Jenni R, Luescher TF, Eberli FR (2009) Percutaneous PFO closure with Amplatzer PFO occluder: predictors of residual shunts at 6 months follow-up. Congenit Heart Dis 4:252–257
Gristina AG (1994) Implant failure and the immuno-incompetent fibro-inflammatory zone. Clin Orthop Relat Res 298:106–118
Grosse Meininghaus D, Kruells-Muench J, Peltroche-Llacsahuanga H (2020) First-in-man implantation of a gold-coated biventricular defibrillator: difficult differential diagnosis of metal hypersensitivity reaction vs chronic device infection. HeartRhythm Case Rep 6:304–307
Hagen PT, Scholz DG, Edwards WD (1984) Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 59:17–20
Hanna RN, Carlin LM, Hubbeling HG, Nackiewicz D, Green AM, Punt JA, Geissmann F, Hedrick CC (2011) The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C− monocytes. Nat Immunol 12:778
Haynes DR, Boyle SJ, Rogers SD et al (1998) Variation in cytokines induced by particles from different prosthetic materials. Clin Orthop Relat Res:223–230
Henderson E, Nash DH, Dempster WM (2011) On the experimental testing of fine Nitinol wires for medical devices. J Mech Behav Biomed Mater 4:261–268
Hettinger J, Richards DM, Hansson J, Barra MM, Joschko A-C, Krijgsveld J, Feuerer M (2013) Origin of monocytes and macrophages in a committed progenitor. Nat Immunol 14:821–830
Hofmann U, Frantz S (2015) Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction. Circ Res 116:354–367
Hopewell J (1990) The skin: its structure and response to ionizing radiation. Int J Radiat Biol 57:751–773
Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104:2752–2760
Ipach I, Schäfer R, Mittag F et al (2012) The development of whole blood titanium levels after instrumented spinal fusion - is there a correlation between the number of fused segments and titanium levels? BMC Musculoskelet Disord 13:159
Ito M, Tada N, Hata M (2017) Balloon repositioning of Transcatheter Aortic Valve after migration into the left ventricular outflow tract, followed by Valve-in-Valve procedure. Tex Heart Inst J 44:274–278
Jana S (2019) Endothelialization of cardiovascular devices. Acta Biomater 99:53–71
Jose J, Richardt G, Abdel-Wahab M (2015) Balloon- or self-expandable TAVI: clinical equipoise? Interv Cardiol 10:103–108
Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H, Izawa A, Takahashi Y, Masumoto J, Koyama J (2011) Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 123:594–604
Keiler J, Schulze M, Sombetzki M et al (2017) Neointimal fibrotic lead encapsulation - clinical challenges and demands for implantable cardiac electronic devices. J Cardiol 70:7–17
Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A (2008) HMGB1: endogenous danger signaling. Mol Med 14:476–484
Knepp MD, Rocchini AP, Lloyd TR et al (2010) Long-term follow up of secundum atrial septal defect closure with the amplatzer septal occluder. Congenit Heart Dis 5:32–37
Komar M, Przewlocki T, Olszowska M, Sobien B, Podolec P (2014) The benefit of atrial septal defect closure in elderly patients. Clin Interv Aging 9:1101
Kono H, Kimura Y, Latz E (2014) Inflammasome activation in response to dead cells and their metabolites. Curr Opin Immunol 30:91–98
Kono H, Rock KL (2008) How dying cells alert the immune system to danger. Nat Rev Immunol 8:279–289
Kramer DB, Kesselheim AS (2015) The Watchman saga--closure at last? N Engl J Med 372:994–995
Krizanic F, Sievert H, Pfeiffer D et al (2010) The Occlutech Figulla PFO and ASD occluder: a new nitinol wire mesh device for closure of atrial septal defects. J Invasive Cardiol 22:182–187
Kumar P, Sarkar A, Kar SK (2019) Assessment of ventricular function in patients of atrial septal defect by strain imaging before and after correction. Ann Card Anaesth 22:41
Kypta A, Blessberger H, Kammler J, Lichtenauer M, Lambert T, Silye R, Steinwender C (2016) First autopsy description of changes 1 year after implantation of a leadless cardiac pacemaker: unexpected ingrowth and severe chronic inflammation. Can J Cardiol 32:1578. e1571–1578. e1572
Kypta A, Blessberger H, Lichtenauer M, Lambert T, Kammler J, Steinwender C (2015) Gold-coated pacemaker implantation for a patient with type IV allergy to titanium. Indian Pacing Electrophysiol J 15:291–292
Lacey DC, De Kok B, Clanchy FI et al (2009) Low dose metal particles can induce monocyte/macrophage survival. J Orthop Res 27:1481–1486
Lai S-L, Marín-Juez R, Stainier DY (2019) Immune responses in cardiac repair and regeneration: a comparative point of view. Cell Mol Life Sci 76:1365–1380
Latz E, Xiao TS, Stutz A (2013) Activation and regulation of the inflammasomes. Nat Rev Immunol 13:397–411
Le Gloan L, Legendre A, Iserin L, Ladouceur M (2018) Pathophysiology and natural history of atrial septal defect. J Thorac Dis 10:S2854
Lee PH, Song JK, Kim JS et al (2018) Cryptogenic stroke and high-risk patent foramen Ovale: the DEFENSE-PFO trial. J Am Coll Cardiol 71:2335–2342
Leon MB, Smith CR, Mack M et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607
Li D-W, Liu Z-Q, Wei J, Liu Y, Hu L-S (2012) Contribution of endothelial progenitor cells to neovascularization. Int J Mol Med 30:1000–1006
Luttikhuizen DT, Harmsen MC, Luyn MJV (2006) Cellular and molecular dynamics in the foreign body reaction. Tissue Eng 12:1955–1970
Madhkour R, Wahl A, Praz F, Meier B (2019) Amplatzer patent foramen ovale occluder: safety and efficacy. Expert Rev Med Devices 16:173–182
Maleckis K, Anttila E, Aylward P et al (2018) Nitinol stents in the Femoropopliteal artery: a mechanical perspective on material, design, and performance. Ann Biomed Eng 46:684–704
Martinez FO, Gordon S (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000prime Rep 6
Mas JL, Derumeaux G, Chatellier G (2017) Trials of patent foramen Ovale closure. N Engl J Med 377:2599–2600
Masura J, Gavora P, Formanek A et al (1997) Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Catheter Cardiovasc Diagn 42:388–393
Masura J, Gavora P, Podnar T (2005) Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders. J Am Coll Cardiol 45:505–507
Mcdonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CC, Beck PL, Muruve DA, Kubes P (2010) Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330:362–366
Meerkin D, Butnaru A, Dratva D et al (2013) Early safety of the Amplatzer cardiac plug™ for left atrial appendage occlusion. Int J Cardiol 168:3920–3925
Meier B (2005) Closure of patent foramen ovale: technique, pitfalls, complications, and follow up. Heart 91:444–448
Mocatta TJ, Pilbrow AP, Cameron VA, Senthilmohan R, Frampton CM, Richards AM, Winterbourn CC (2007) Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 49:1993–2000
Mollova M, Bersell K, Walsh S, Savla J, Das LT, Park S-Y, Silberstein LE, Dos Remedios CG, Graham D, Colan S (2013) Cardiomyocyte proliferation contributes to heart growth in young humans. Proc Natl Acad Sci 110:1446–1451
Mond HG, Proclemer A (2011) The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009–a world Society of Arrhythmia’s project. Pacing Clin Electrophysiol 34:1013–1027
Moons P, Sluysmans T, De Wolf D et al (2009) Congenital heart disease in 111 225 births in Belgium: birth prevalence, treatment and survival in the 21st century. Acta Paediatr 98:472–477
Mund JA, Estes ML, Yoder MC, Ingram DA Jr, Case J (2012) Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells. Arterioscler Thromb Vasc Biol 32:1045–1053
Muzio M, Polntarutti N, Bosisio D, Prahladan M, Mantovani A (2000) Toll like receptor family (TLT) and signalling pathway. Eur Cytokine Netw 11:489–490
Nahrendorf M, Pittet MJ, Swirski FK (2010) Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121:2437–2445
Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo J-L, Libby P, Weissleder R, Pittet MJ (2007) The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 204:3037–3047
Nasakina EO, Sudarchikova MA, Sergienko KV et al (2019) Ion release and surface characterization of nanostructured Nitinol during long-term testing. Nanomaterials (Basel):9
Nashat H, Montanaro C, Li W, Kempny A, Wort SJ, Dimopoulos K, Gatzoulis MA, Babu-Narayan SV (2018) Atrial septal defects and pulmonary arterial hypertension. J Thorac Dis 10:S2953
Nassif M, Abdelghani M, Bouma BJ, Straver B, Blom NA, Koch KT, Tijssen JG, Mulder BJ, De Winter RJ (2016) Historical developments of atrial septal defect closure devices: what we learn from the past. Expert Rev Med Devices 13:555–568
Neuser J, Akin M, Bavendiek U, Kempf T, Bauersachs J, Widder JD (2016) Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla® Flex II Occluder. BMC Cardiovasc Disord 16:1–7
Nicholls M (2020) André F. Cournand for cardiac catheterization: mark Nicholls focusses on the role of Professor André F. Cournand in the development of cardiac catheterization and the award of the 1956 Nobel Prize. Oxford University Press
Nishimura M, Naito S (2005) Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol Pharm Bull 28:886–892
Omdahl P, Eggen MD, Bonner MD et al (2016) Right ventricular anatomy can accommodate multiple Micra Transcatheter pacemakers. Pacing Clin Electrophysiol 39:393–397
Östberg AK, Dahlgren U, Sul YT et al (2015) Inflammatory cytokine release is affected by surface morphology and chemistry of titanium implants. J Mater Sci Mater Med 26:155
Pase L, Layton JE, Wittmann C, Ellett F, Nowell CJ, Reyes-Aldasoro CC, Varma S, Rogers KL, Hall CJ, Keightley MC (2012) Neutrophil-delivered myeloperoxidase dampens the hydrogen peroxide burst after tissue wounding in zebrafish. Curr Biol 22:1818–1824
Pedra CA, Pedra SF, Costa RN, Ribeiro MS, Nascimento W, Campanhã LOS, Santana MVT, Jatene IB, Assef JE, Fontes VF (2016) Mid-term outcomes after percutaneous closure of the secundum atrial septal defect with the Figulla-Occlutech Device. J Interv Cardiol 29:208–215
Peuster M, Fink C, Von Schnakenburg C (2003) Biocompatibility of corroding tungsten coils: in vitro assessment of degradation kinetics and cytotoxicity on human cells. Biomaterials 24:4057–4061
Podnar T, Martanovic P, Gavora P et al (2001) Morphological variations of secundum-type atrial septal defects: feasibility for percutaneous closure using Amplatzer septal occluders. Catheter Cardiovasc Interv 53:386–391
Proclemer A, Ghidina M, Gregori D et al (2010) Trend of the main clinical characteristics and pacing modality in patients treated by pacemaker: data from the Italian pacemaker registry for the quinquennium 2003-07. Europace 12:202–209
Radovsky AS, et al (1988) Paired comparisons of steroid-eluting and nonsteroid endocardial pacemaker leads in dogs: electrical performance and morphologic alterations. Pacing Clin Electrophysiol 11(7):1085–1094. https://doi.org/10.1111/j.1540-8159.1988.tb03955.x. PMID: 2457888
Reddy VY, Exner DV, Cantillon DJ et al (2015) Percutaneous implantation of an entirely Intracardiac leadless pacemaker. N Engl J Med 373:1125–1135
Rehman J, Li J, Orschell CM, March KL (2003) Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107:1164–1169
Renker M, Kim WK (2020) Choice of transcatheter heart valve: should we select the device according to each patient’s characteristics or should it be “one valve fits all”? Ann Transl Med 8:961
Reynolds D, Duray GZ, Omar R, Soejima K, Neuzil P, Zhang S, Narasimhan C, Steinwender C, Brugada J, Lloyd M, Roberts PR, Sagi V, Hummel J, Bongiorni MG, Knops RE, Ellis CR, Gornick CC, Bernabei MA, Laager V, Stromberg K, Williams ER, Hudnall JH, Ritter P (2016) Micra Transcatheter Pacing Study Group A leadless intracardiac transcatheter pacing system. N Engl J Med 374:533–541. https://doi.org/10.1056/NEJMoa1511643
Ries MW, Kampmann C, Rupprecht HJ et al (2003) Nickel release after implantation of the Amplatzer occluder. Am Heart J 145:737–741
Rotman OM, Bianchi M, Ghosh RP, Kovarovic B, Bluestein D (2018) Principles of TAVR valve design, modelling, and testing. Expert Rev Med Devices 15:771–791
Ryhänen J, Kallioinen M, Tuukkanen J et al (1998) In vivo biocompatibility evaluation of nickel-titanium shape memory metal alloy: muscle and perineural tissue responses and encapsule membrane thickness. J Biomed Mater Res 41:481–488
Sadiq M, Kazmi T, Rehman AU et al (2012) Device closure of atrial septal defect: medium-term outcome with special reference to complications. Cardiol Young 22:71–78
Sandberg O, et al (2012) Etanercept does not impair healing in rat models of tendon or metaphyseal bone injury. Acta Orthop 83(3):305–310. https://doi.org/10.3109/17453674.2012.693018. Epub 2012 May 23. PMID: 22616743; PMCID: PMC3369160
Sattler S, Rosenthal N (2016) The neonate versus adult mammalian immune system in cardiac repair and regeneration. Biochimica et Biophysica Acta (BBA)-Mol Cell Res 1863:1813–1821
Saver JL, Committee RTS (2017) Trials of patent foramen Ovale closure. N Engl J Med 377:2600
Saw J, Lopes JP, Reisman M et al (2016) Cardiac computed tomography angiography for left atrial appendage closure. Can J Cardiol 32:1033.e1031–1033.e1039
Saylor DM, Craven BA, Chandrasekar V et al (2018) Predicting patient exposure to nickel released from cardiovascular devices using multi-scale modeling. Acta Biomater 70:304–314
Scalise F, Auguadro C, Sorropago G et al (2016) Long-term contrast echocardiography and clinical follow-up after percutaneous closure of patent foramen Ovale using two different atrial septal Occluder devices. J Interv Cardiol 29:406–413
Schwartz RS, Holmes DR, Van Tassel RA et al (2010) Left atrial appendage obliteration: mechanisms of healing and intracardiac integration. JACC Cardiovasc Interv 3:870–877
Sellers SL, Blanke P, Leipsic JA (2019) Bioprosthetic heart valve degeneration and dysfunction: focus on mechanisms and multidisciplinary imaging considerations. Radiol Cardiothorac Imaging 1:e190004
Shayan M, Chun Y (2015) An overview of thin film nitinol endovascular devices. Acta Biomater 21:20–34. https://doi.org/10.1016/j.actbio.2015.03.025. Epub 2015 Mar 31
Shukla R, Bansal V, Chaudhary M et al (2005) Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 21:10644–10654
Sievert H, Babic UU, Hausdorf G et al (1998) Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial). Am J Cardiol 82:1405–1413
Sigler M, Bartmus D, Paul T (2005a) Histology of a surgically removed stenotic modified Blalock-Taussig shunt after previous endovascular stenting. Heart 91:1097
Sigler M, Paul T, Grabitz RG (2005b) Biocompatibility screening in cardiovascular implants. Z Kardiol 94:383–391
Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ (2009) HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28:367–388
Singh M, Saini HK (2003) Resident cardiac mast cells and ischemia-reperfusion injury. J Cardiovasc Pharmacol Ther 8:135–148
Smiley ST, King JA, Hancock WW (2001) Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 167:2887–2894
Soehnlein O, Lindbom L (2010) Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 10:427–439
Søndergaard L, Kasner SE, Rhodes JF et al (2017) Patent foramen Ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med 377:1033–1042
Stoeckel D, Pelton A, Duerig T (2004) Self-expanding nitinol stents: material and design considerations. Eur Radiol 14:292–301
Stokes KB, Bird T, Gunderson B (1991) The mythology of threshold variations as a function of electrode surface area. Pacing Clin Electrophysiol 14:1748–1751
Sun JS, Lin FH, Tsuang YH et al (2000) Effect of anti-inflammatory medication on monocyte response to titanium particles. J Biomed Mater Res 52:509–516
Talman V, Ruskoaho H (2016) Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration. Cell Tissue Res 365:563–581
Tang L, Jennings TA, Eaton JW (1998) Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc Natl Acad Sci 95:8841–8846
Thannickal VJ, Fanburg BL (2000) Reactive oxygen species in cell signaling. Am J Phys Lung Cell Mol Phys 279:L1005–L1028
Timmers L, Sluijter JP, Van Keulen JK, Hoefer IE, Nederhoff MG, Goumans M-J, Doevendans PA, Van Echteld CJ, Joles JA, Quax PH (2008) Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res 102:257–264
Tjong FV, Stam OC, Van Der Wal AC et al (2015) Postmortem histopathological examination of a leadless pacemaker shows partial encapsulation after 19 months. Circ Arrhythm Electrophysiol 8:1293–1295
Tramontana M, Bianchi L, Hansel K et al (2020) Nickel allergy: epidemiology, Pathomechanism, clinical patterns, treatment and prevention programs. Endocr Metab Immune Disord Drug Targets 20:992–1002
Ungersboeck A, Geret V, Pohler O et al (1995) Tissue reaction to bone plates made of pure titanium: a prospective, quantitative clinical study. J Mater Sci Mater Med 6:223–229
Wan E, Yeap XY, Dehn S, Terry R, Novak M, Zhang S, Iwata S, Han X, Homma S, Drosatos K (2013) Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circ Res 113:1004–1012
Wang R, Kawashima H, Mylotte D, Rosseel L, Gao C, Aben J-P, Abdelshafy M, Onuma Y, Yang J, Soliman O (2021) Quantitative angiographic assessment of aortic regurgitation after transcatheter implantation of the Venus A-valve: comparison with other self-expanding valves and impact of a learning curve in a single Chinese center. Glob Heart 16(1):20
Weirather J, Hofmann UD, Beyersdorf N, Ramos GC, Vogel B, Frey A, Ertl G, Kerkau T, Frantz S (2014) Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ Res 115:55–67
Welt FG, Rogers C (2002) Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 22:1769–1776
Witten ML, Sheppard PR, Witten BL (2012) Tungsten toxicity. Chem Biol Interact 196:87–88
Yao B, La LB, Chen YC, Chang LJ, Chan EK (2012) Defining a new role of GW182 in maintaining miRNA stability. EMBO Rep 13:1102–1108
Yona S, Kim K-W, Wolf Y, Mildner A, Varol D, Breker M, Strauss-Ayali D, Viukov S, Guilliams M, Misharin A (2013) Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38:79–91
Youker K, Smith CW, Anderson DC, Miller D, Michael LH, Rossen RD, Entman ML (1992) Neutrophil adherence to isolated adult cardiac myocytes. Induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest 89:602–609
Zahn EM, Wilson N, Cutright W et al (2001) Development and testing of the Helex septal occluder, a new expanded polytetrafluoroethylene atrial septal defect occlusion system. Circulation 104:711–716
Zdolsek J, Eaton JW, Tang L (2007) Histamine release and fibrinogen adsorption mediate acute inflammatory responses to biomaterial implants in humans. J Transl Med 5:1–6
Zhang Q, Hitchins VM, Schrand AM et al (2011) Uptake of gold nanoparticles in murine macrophage cells without cytotoxicity or production of pro-inflammatory mediators. Nanotoxicology 5:284–295
Zouggari Y, Ait-Oufella H, Waeckel L, Vilar J, Loinard C, Cochain C, Recalde A, Duriez M, Levy BI, Lutgens E (2009) Regulatory T cells modulate postischemic neovascularization. Circulation 120:1415
Zymek P, Bujak M, Chatila K, Cieslak A, Thakker G, Entman ML, Frangogiannis NG (2006) The role of platelet-derived growth factor signaling in healing myocardial infarcts. J Am Coll Cardiol 48:2315–2323
Acknowledgments
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. We would like to express our gratitude to the companies mentioned in the journal for permission to reprint the product images.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Edlinger, C. et al. (2022). Endothelialization and Inflammatory Reactions After Intracardiac Device Implantation. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 17. Advances in Experimental Medicine and Biology(), vol 1401. Springer, Cham. https://doi.org/10.1007/5584_2022_712
Download citation
DOI: https://doi.org/10.1007/5584_2022_712
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-20513-2
Online ISBN: 978-3-031-20514-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)